Dr. Mark H. Tuszynski's lab focuses on understanding and promoting recovery after spinal cord injuries in primates. Using advanced techniques, the lab investigates how injured spinal neurons can regenerate and form new connections, which could lead to improved voluntary motor control. Their research aims to identify optimal time points for intervention and to enhance the effectiveness of neural stem cell therapies for spinal cord healing.

Dr. Robert Rennaker's lab focuses on improving recovery after spinal cord injuries, particularly in restoring walking abilities. They utilize a technique called vagus nerve stimulation alongside rehabilitation exercises to promote healing and functional recovery in patients. The lab is involved in clinical trials to evaluate the effectiveness of these innovative therapies in helping individuals regain mobility and improve their quality of life.

The research lab led by Dr. Serena Spudich focuses on understanding how HIV affects the central nervous system (CNS) and contributes to cognitive and mental health issues in individuals living with HIV. They use advanced techniques to study HIV persistence in the brain, particularly in individuals on antiretroviral therapy (ART), and investigate how the immune response and viral characteristics relate to neuropsychiatric outcomes. This work aims to uncover new therapies that can enhance mental health for people living with HIV.

Dr. Jeffrey Statland's research lab focuses on improving treatments for facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder that primarily affects children and young adults. The lab aims to validate clinical outcome measures and biomarkers that can help in the development of effective therapies. By conducting prospective studies on pediatric FSHD, the lab hopes to enhance the understanding of the disease and accelerate the process of bringing new treatments to patients.

Dr. Kathy Steece-Collier's lab focuses on developing gene therapy techniques to treat levodopa-induced dyskinesia (LID), a painful side effect of Parkinson's disease medications. The lab investigates how silencing specific calcium channels in the brain can help prevent or reverse LID, especially in older patients and those with varying onset ages. Ultimately, the goal is to improve the quality of life for people living with Parkinson’s disease by exploring new therapeutic options for LID.

Dr. Thomas A. Rando's lab at UCLA focuses on understanding how aging affects stem cells and exploring ways to enhance their function. They investigate the molecular changes that occur in stem cells over time and how these changes contribute to age-related declines in tissue repair and homeostasis. The research aims to develop interventions that can rejuvenate aged stem cells, which may lead to better therapeutic strategies for health issues in the elderly.

Dr. Claude Steriade's research lab at NYU School of Medicine focuses on advancing the diagnosis and treatment of autoimmune epilepsy. By using innovative imaging techniques like TSPO-PET and MRI, the lab aims to uncover the underlying neuroinflammatory processes that contribute to the condition. The ultimate goal is to develop more effective diagnostic markers and treatment strategies for patients suffering from this complex disorder.

Dr. Yaakov Stern's lab at Columbia University focuses on understanding the relationship between cognitive aging and Alzheimer’s disease (AD). The team uses advanced imaging techniques to explore how neural networks associated with memory and other cognitive abilities change with age and how modern family and work life impacts the risk of developing Alzheimer's disease. By studying diverse populations, they aim to identify key factors that could help prevent cognitive decline in older adults.

Dr. Shinjae Chung's lab at the University of Pennsylvania investigates how stress affects sleep patterns and cognitive function. They study the neural circuits involved in sleep regulation and how disturbances in sleep due to stress can lead to memory issues and affect mental health. The ultimate goal is to uncover insights that could lead to new therapies for sleep disorders triggered by stress.

Dr. Marc V Fuccillo's lab at the University of Pennsylvania focuses on understanding how specific types of neurons in the brain's striatum contribute to controlling behaviors and decisions. By studying interactions between different neuron types and neurotransmitters, the lab seeks to uncover the biological basis of goal-directed behaviors, which can be disrupted in various neuropsychiatric disorders. Their research combines advanced techniques such as optogenetics and calcium imaging to investigate both molecular mechanisms and circuit functions in real-time.

Dr. Stephen Strittmatter's lab at Yale University focuses on understanding the mechanisms of synapse loss in Alzheimer's disease. The research investigates how a specific receptor in the brain, called mGluR5, contributes to the disease's progression and memory impairment. By using advanced imaging techniques and genetic models, the lab aims to discover new therapeutic approaches to prevent synapse loss and improve brain function in Alzheimer's patients.

Dr. Shyam Prabhakaran's research focuses on improving the emergency evaluation and transfer processes for stroke patients. His lab conducts studies that aim to enhance the Door-In-Door-Out (DIDO) protocol to ensure patients get timely access to comprehensive stroke care. Through interdisciplinary collaboration, the lab seeks to develop and implement effective strategies that can reduce delays in treatment and improve outcomes for stroke patients nationwide.

Dr. Ying Xian's lab focuses on understanding how strokes can lead to cognitive impairment and dementia, a condition known as post-stroke cognitive impairment and dementia (PSCID). The lab aims to use large datasets to identify risk factors for PSCID and explore how certain medications might help prevent it. Through this research, they hope to improve the care and treatment plans for stroke survivors and contribute to public health strategies targeting dementia related to strokes.

Dr. Boryana Stamova's research lab focuses on understanding how changes in gene expression in blood can help predict recovery outcomes after an ischemic stroke. By studying RNA from patients shortly after a stroke, the lab aims to uncover new biomarkers that are more effective than traditional clinical measures. This research could lead to better patient treatment options and personalized approaches to stroke recovery.

Dr. Anjali Chauhan's lab explores how biological and immune factors, particularly the IL6 signaling pathway, affect stroke recovery in older women. The research aims to uncover differences in recovery outcomes between sexes, specifically focusing on how inflammation and microglial signaling influence brain injury and cognitive decline following strokes. The goal is to provide insights that could lead to better, sex-specific treatments for stroke survivors.

Dr. Pooja Khatri's lab at Yale University focuses on understanding how to better predict recovery outcomes for patients who have suffered a stroke, particularly concerning their upper extremity function. They are investigating the use of advanced imaging techniques and brain stimulation to identify patients who will benefit from specific treatments in the early stages after a stroke. This research aims to enhance personalized rehabilitation strategies for improving motor function in stroke survivors.

Dr. Steven C. Cramer's lab focuses on innovative rehabilitation methods for stroke recovery. They are particularly interested in using telerehabilitation techniques to help patients improve their arm function from the comfort of home. By employing intensive rehabilitation strategies, their research aims to determine how these approaches can enhance recovery outcomes and patient quality of life after stroke.

Dr. Hume Akahori Stroud's research lab focuses on understanding the molecular mechanisms behind neurodevelopmental disorders like Rett Syndrome and autism. The lab studies the roles of important proteins, such as MECP2 and DNMT3A, in gene regulation within the brain. By exploring how these proteins interact with DNA and affect gene expression, the lab aims to uncover new strategies for treating these neurological conditions.

Dr. Hal Blumenfeld's lab at Yale University focuses on understanding how subcortical brain systems influence our perception across different senses like sight, sound, and touch. By analyzing brain activity during sensory experiences, they explore how transient increases in brain activity can enhance our awareness of these stimuli. Their research aims to uncover fundamental neural circuits that could help improve therapies for cognitive disorders that impair perception.

Daniel A Colon-Ramos' lab at Yale University focuses on understanding the biology of synapses, which are crucial for communication between nerve cells and play a key role in how we learn and remember. The lab explores how synapses are formed and modified during development and learning, aiming to uncover the principles that govern behavior through neural circuitry. Their research not only deepens our understanding of basic neuroscience but also sheds light on conditions like neurodegeneration and disorders of brain development.